Aims/hypothesis. Several studies have suggested a predisposing role of the e4 allele of apolipoprotein E (ApoE) in the development of atherosclerosis and cardiovascular disease in Type 2 diabetes. Therefore, we hypothesized that the e4 allele is also a risk factor for endothelial dysfunction. We attempted to assess whether Apo e4 allele is associated with endothelial dysfunction in the early stage of Type 2 diabetes. Methods. We selected 255 Chinese Han Type 2 diabtetic men without angiopathy. PCR or allele-specific oligonucleotide probes were used to analyse ApoE genotypes, and high resolution ultrasound was used to measure brachial artery diameter at rest, after reactive hyperaemia and after sublingual glyceryltrinitrate. Results. The flow-mediated arterial dilation among the subjects with e4/3 or e4/4 was 3.14±0.32%, which was lower than that in subjects with e2/2 or e3/2 (4.04±0.30%) (p=0.038). The baseline vessel size, glyceryltrinitrate-induced arterial dilation and baseline flow were not different among different ApoE genotypes. On univariate analysis, reduced flow-mediated arterial dilation was related to total cholesterol, LDL, lipoprotein(a) [Lp(a)], high blood pressure, older age, family history of premature vascular disease, larger vessel size, cigarette smoking, duration of diabetes and e4 allele (p<0.05). By multiple stepwise regression analysis, reduced flow-mediated arterial dilation was associated with cigarette smoking, LDL, Lp(a), and e4 allele (p<0.01). Conclusion/interpretation. Apo e4 allele is associated with impairment of endothelium-dependent arterial dilation in the early stage of Type 2 diabetes. [Diabetologia (2003) 46:514-519] 
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Department of Endocrinology, Wuhan General Hospital, Wuhan, People's Republic of China B/E receptor [1] . In humans, the gene locus for ApoE have three common alleles, e2, e3, and e4, which encode three major isoforms, e2, e3 and e4, yielding six common genotypes, e2/2, e4/2, e3/2, e3/3, e4/3 and e4/4 [1] .
In non-diabetic population, many studies [2, 3, 4, 5, 6] showed that the Apo e4 allele is associated with the risk of myocardial infarction, the increased severity of coronary artery disease defined by angiography, as well as the increased occurrence of exercise-induced silent myocardial ischaemia. Recently, several studies showed that Apo e4 allele is also associated with the risk of coronary artery disease [7, 8] and the increased occurrence of exercise-induced silent myocardial ischaemia [9] in Type 2 diabetic patients. To date, no data are available on the role of ApoE genotypes in endoApolipoprotein E (Apo E) is one of the major proteins involved in catabolism of triglyceride-rich lipoproteins (VLDL) and remnants. ApoE acts as ligand for two receptors: the "remnants" receptor and the Apo thelial dysfunction. Endothelial dysfunction is an early physiological event in atherosclerosis [10] . Therefore, we hypothesized that e4 allele is also a risk factor for endothelial dysfunction. The purpose of this study was to investigate the relationship between the Apo e4 allele and endothelial dysfunction in Type 2 diabetes mellitus without clinically detectable angiopathy.
Subjects and methods
Subjects. The study population included 255 Chinese Han Type 2 diabetic men referred to our hospital, between 40 to 68 years of age, mean age 58±8 years. Those patients with microangiopathy and macroangiopathy including nephropathy (urinary albumin excretion rate >20 µg/min), retinopathy (at least one microaneurysm or haemorrhage or exudates in either eye), neuropathy (pain in extremities, paresthesias and absent tendon reflexes and/or absent vibration sense), coronary artery disease (myocardial infarction, ischaemia, ECG changes and angina), cerebrovascular disease (transient ischaemic attack or stroke), and peripheral vascular disease (intermittent claudication), and with hypertension were excluded. Each subject was asked details of his smoking history and family history of premature vascular disease. Cigarette smokers were defined as subjects who had smoked at least one cigarette daily for 1 year. Family history was considered positive if a first-degree relative had had clinical evidence of coronary artery disease (angina, myocardial infarction or bypass surgery) at a younger age than 55 years. All the subjects gave informed consent and volunteered for the study which was approved by the Wuhan General Hospital ethics committee.
Methods. Venous blood samples were drawn after a 12-to 14-h overnight fast. Postprandial 2-h blood samples (during an OGTT) were drawn for postprandial blood glucose (PPBG). Measurement of serum lipids, lipoproteins and other parameters, serum total cholesterol, LDL, triglyceride, HDL, were measured enzymatically. Apolipoprotein A1 (ApoA1) and ApoB were measured by immunoturbidimetry. Serum glucose, including fasting blood glucose (FBG) and PPBG were measured by a glucose oxidase procedure. Serum lipoprotein (a) [Lp(a)] concentrations were measured by an ELISA method. Haemoglobin A 1c was measured by high-performance chromatography. Coefficients of variation for these assays were 1 to 2% (glucose), 1 to 2% (total cholesterol), 2 to 3% (LDL), 1 to 2% (HDL), 2 to 4% (ApoA 1 and ApoB), 4 to 7% [Lp(a)], and 1 to 2% (haemoglobinA 1c) .
The vascular studies of the brachial artery were done noninvasively, as described previously [11] . High resolution ultrasound was used to measure changes in arterial diameter in response to reactive hyperaemia (with increased flow producing an endothelium-dependent stimulus to vasodilation) and to glyceryltrinitrate (GNT, an endothelium-independent vasodilator) (128XP/10 with a 7.0 MHZ linear array transducer: Acuson, Mountain View, Calif., USA).
The subjects rested in the supine position for 10 min before the first scan and remained supine throughout the study. The target artery (the brachial 2-15 cm above the elbow) was scanned in longitudinal section and the center of the vessel was identified when the clearest images of anterior and posterior walls of the artery were obtained. The transmit zone was set to the level of the anterior vessel wall. Depth and gain settings were optimized to identify the lumen to vessel wall interface.
Images were magnified with the resolution box function leading to a television line width of ~0.05 mm. Machine settings were kept constant during each study.
Flow increase was induced by inflation of a blood pressure tourniquet placed around the forearm distal to the target artery, to 300 mmHg. The cuff was released after 4 to 5 min and after cuff deflation the artery was scanned continuously for 90 s. A total of 15 min was allowed for vessel recovery, then sublingual GNT (400-µg spray) was administered, and 4 to 5 min later the last scan was done. The electrocardiogram was monitored continuously.
Vessel diameter was measured by two observers, unaware of clinical details and the stage of the experiment. The arterial diameter was measured at a fixed distance from an anatomical maker, such as a bifurcation, with ultrasonic calipers. Measurements were taken from the anterior to the posterior "m" line at end diastole, incident with the R-wave on the electrocardiogram. The mean diameter was calculated from four cardiac cycles. For the hyperaemia scan, vessel diameter was measured 45 to 60 s after cuff release. Diameter changes were derived as percent change relative to the first baseline scan (100%). Baseline blood flow (measured during the first baseline scan) was estimated by multiplying angle-corrected, pulsed Doppler recordings of the flow-velocity integral by JI and the square of the radius of the artery.
ApoE genotyping, Genomic DNA was extracted from mouthwash water [12] . ApoE genotypes were analysed using polymerase chain reaction ( PCR) or allele-specific oligonucleotide probe technique according to our previous report [9] . PCR was used to amplify a 330 bp region spanning both e2/e3 and e3/e4 allelic sites [13] . PCR primers used were P 1 5′-TCCAAGGAG CTGCAGGCGGCGCA-3′, and P 2 5′-TAG-CGGCTGGCCGGCCAGGGAG-3′. The allele-specific probes used to detect variation at amino acid 158 were A8 5′-CTGC-AGAAGCGCCTGGCAGTG-3′ e3 (e3) ASO and C8 5′-CAC-TGCCAGGCACTTCTGCAG-3′ e2 (e2) ASO, and at amino acid 112 were A2 5′-GAGGACGTGCGCGGCCGCCTG-3′ e4 (e4) ASO, and C2 5′-CAG GCGGCCGCACACGTCCTC -3′ e3 (e3) ASO [13] .
Statistical methods. The number of a given allele, e.g., e3, in the pair of alleles can be 0, 1, or 2, corresponding to individual relative frequencies of 0%, 50%, 100%, respectively. A carrier of a specific e allele was a subject carrying the e4, e3, or e2 genotype in homo-or heterozygous form. Comparison between more than two groups was done by the Chi square test with Yate correction or the ANOVA. Comparison between two groups was done by the Chi square test or Student's t test for independent samples when appropriate. Univariate analysis of the effects of each potential risk factor on flow-mediated arterial dilation and nitroglycerin response was done with linear regression for continuous variables (total cholesterol, LDL, HDL, triglycerides, Lp(a), ApoA1, ApoB, mean blood pressure, age, duration of diabetes, vessel size, blood flow and with one-way analysis of variance for categoric variables (family history, smoking, e2, e3, and e4). The relation between risk factors and flow-mediated dilation or nitroglycerin was then examined using multiple stepwise regression analysis. Lp(a) concentrations were log-transformed before analysis. All analyses were carried out by using the statistical package SAS. e4/2 was excluded from the analysis because of the very low prevalence and the contrary effect on serum lipids between e4 and e2.
Results
The ApoE genotype prevalence was as follows: 1.6% for e2/2, 0.8% for e4/2, 11.8% for e3/2, 63.1% for e3/3, 19.6% for e4/3, and 3.1% for e4/4. The observed distribution of ApoE genotypes was in Hardy-Weinberg equilibrium. Serum total cholesterol and LDL concentrations were higher in subjects with e4/3 or e4/4 than in subjects with e2/2 or e3/2 (p=0.021). Lp(a) concentration was lower in subjects with e2/2 or e3/2 than in subjects with e3/3 and e4/3 or e4/4 (p=0.043). Other serum lipid and lipoprotein concentrations did not differ among the ApoE genotypes (Table 1) . With respect to clinical characteristics and metabolic control of diabetes, the ApoE genotype groups did not differ from each other ( Table 2) . Table 3 shows the results of brachial artery studies by ApoE genotypes. The flow-mediated arterial dilation among the subjects with genotype e4/3 or e4/4 was 3.14±0.32%, which was lower than those in subjects with e2/2 or e3/2 (4.04±0.30%) (p=0.038). The baseline vessel size (diameter), GNT-induced arterial dilation and baseline flow were not significantly different among different ApoE genotypes.
Univariate analysis showed a correlation between flow-mediated arterial dilation and high total cholesterol concentration (r=−0. 23 
Discussion
Endothelial dysfunction is an important early event in atherogenesis [14, 15] . Both spatial and temporal correlations between endothelial dysfunction and coronary atherosclerosis have been shown in animal models and in humans [16, 17, 18] . Impairment of endothelial function in early life could result in abnormal reactions between the vessel wall and platelets, neutrophils, and macrophages, and thus could contribute to the initial stages of atherogenesis [14] . However, the underlying mechanisms of the relationship between Apo e4 allele and the impairment of endothelial function are not clear. Our subjects were Type 2 diabetic men without clinically detectable angiopathy and hypertension, indicating they are in the early stage of diabetes. No significant differences on clinical characteristics, such as age, BMI, blood pressure, blood sugar, cigarette smoking, duration of diabetes, family history, were found among different ApoE genotype groups, indicating that susceptibility to impairment of endothelium-dependent arterial dilation cannot be explained by classic risk factors alone [19, 20] . Endothelial injury has been induced experimentally by hypercholesterolaemia, particularly the LDL component [21] . In clinical studies using invasive techniques, hypercholesterolaemic adults have been shown to have impaired endothelium-dependent responses to a variety of pharmacologic stimuli, including infusions of acetyleholine [22, 23] . Recently, another study using a noninvasive method, showed that impaired endothelium-dependent arterial dilation is present in children with familial hypercholesterolaemia as young as 7 years of age [24] . In the present study, compared with subjects with e2 allele, the subjects with e4 allele have higher total cholesterol, and LDL concentrations. Flow-mediated arterial dilation was correlated with LDL and e4 allele, which are in good agreement with previous studies [2, 3, 4, 5, 6, 7, 8, 9] . These can explain partially the impairment of endothelial-dependent arterial dilation in people with the e4 allele. Lp(a) is an independent risk factor for atherosclerotic vascular disease [25, 26] . Many prospective studies have shown that excess Lp(a) is associated with premature coronary atherosclerosis and risk of cardiovascular disease [27, 28] . Moreover, increased plasma Lp(a) concentrations have been associated with subclinical carotid atherosclerosis in patients with Type 2 diabetes mellitus in some studies [29] , but not all [30] . The mechanism by which high concentrations of Lp(a) are related to atherosclerosis is not clear, but Lp(a) could interfere with intravascular thrombolysis and inhibit the streptokinaze-mediated conversion of plasmin from plasminogen. In addition, Lp(a) is found within atherosclerotic plaque and could contribute to cholesterol ester accumulation within the plaque [31] . In 1994, a relation between Lp(a) and impaired endothelium-dependent arterial dilation in 1 to 17 years old children with familial hypercholesterolaemia, independent of the total cholesterol concentration was reported [24] . More recently, a study showed that increased Lp(a) concentrations are associated with an impaired endothelial function in healthy postmenopausal women, independent of conventional risk factors for cardiovascular disease [32] . Our data showed a negative relation between plasma Lp(a) concentrations and endothelium-dependent arterial dilation, and the Lp(a) concentrations in subjects with e2/2 or e3/2 were lower than those in subjects with e3/3 as well as subjects with e4/3 or e4/4. These can also explain partially the impairment of endotheliumdependent arterial dilation in people with the e4 allele in the early stage of Type 2 diabetes mellitus.
Smoking has long been recognised as one of the major risks for vascular disease. It is associated with severe aortic atherosclerosis in patients over 25 years of age [33] and with early lesions in patients younger than 25 years [34] . Previously, several studies showed that cigarette smoking is associated with impaired endothelium-dependent arterial dilation in healthy people [11, 19, 32, 35] . Furthermore, exposure to heavy environmental tobacco smoke (passive smoking) can also cause impairment of endothelium-dependent arterial dilation. We also found simillar results in the early stage of Type 2 diabetes mellitus in men. In addition, aging and a positive family history of premature vascular disease are two of the risk factors that are correlated with endothelial dysfunction [19] , this association was detected in our study as well. In summary, these results showed an association between the Apo e4 allele and endothelium-dependent arterial dilation in the early stage of Type 2 diabetes mellitus, although the mechanism for the association has not been explained completely. 
